Incretin Secretion Study

About this Study

Abnormalities in blood glucose and insulin secretion may be present long before the development of diabetes in CF. However, these differences have not been well-studied.

This study hopes to characterize insulin secretion in CF patients with a range of glucose tolerance abnormalities. This knowledge will allow for better understanding of the potential differences in insulin secretion defects across categories of glucose tolerance. The information obtained will hopefully lead to a better understanding of the progression of CFRD and potential interventions to slow or prevent this progression.